Critical Review: Fresenius SE & Co. (FSNUY) & Its Competitors

Fresenius SE & Co. (OTCMKTS:FSNUY – Get Free Report) is one of 511 public companies in the “Healthcare Equipment & Supplies” industry, but how does it contrast to its peers? We will compare Fresenius SE & Co. to similar companies based on the strength of its analyst recommendations, dividends, institutional ownership, profitability, earnings, valuation and risk.

Volatility & Risk

Fresenius SE & Co. has a beta of 0.63, meaning that its share price is 37% less volatile than the S&P 500. Comparatively, Fresenius SE & Co.’s peers have a beta of 2.56, meaning that their average share price is 156% more volatile than the S&P 500.

Profitability

This table compares Fresenius SE & Co. and its peers’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Fresenius SE & Co. 6.58% 10.24% 4.94%
Fresenius SE & Co. Competitors -305.24% -170.58% -22.05%

Earnings & Valuation

This table compares Fresenius SE & Co. and its peers gross revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Fresenius SE & Co. $25.87 billion $1.43 billion 18.15
Fresenius SE & Co. Competitors $1.88 billion $138.79 million 10.04

Fresenius SE & Co. has higher revenue and earnings than its peers. Fresenius SE & Co. is trading at a higher price-to-earnings ratio than its peers, indicating that it is currently more expensive than other companies in its industry.

Analyst Ratings

This is a summary of recent recommendations for Fresenius SE & Co. and its peers, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Fresenius SE & Co. 0 0 3 0 3.00
Fresenius SE & Co. Competitors 4279 10550 18327 829 2.46

As a group, “Healthcare Equipment & Supplies” companies have a potential upside of 21.34%. Given Fresenius SE & Co.’s peers higher possible upside, analysts clearly believe Fresenius SE & Co. has less favorable growth aspects than its peers.

Institutional & Insider Ownership

40.5% of shares of all “Healthcare Equipment & Supplies” companies are held by institutional investors. 14.8% of shares of all “Healthcare Equipment & Supplies” companies are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Dividends

Fresenius SE & Co. pays an annual dividend of $0.20 per share and has a dividend yield of 1.4%. Fresenius SE & Co. pays out 25.0% of its earnings in the form of a dividend. As a group, “Healthcare Equipment & Supplies” companies pay a dividend yield of 2.2% and pay out 46.4% of their earnings in the form of a dividend.

Summary

Fresenius SE & Co. beats its peers on 9 of the 15 factors compared.

About Fresenius SE & Co.

(Get Free Report)

Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment provides dialyzers, dialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients. This segment offers I.V. generic drugs; biosimilar drugs for autoimmune diseases and oncology; enteral and parenteral nutrition products; medical technologies, as well as disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment provides clinical and nursing care facilities. The Fresenius Vamed segment provides services for hospitals and other healthcare facilities. This segment also offers operational management of healthcare facilities and provides services to patients. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.

Receive News & Ratings for Fresenius SE & Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius SE & Co. and related companies with MarketBeat.com's FREE daily email newsletter.